AKINow Mission
To promote excellence in the prevention and treatment of Acute Kidney Injury (AKI) by building a foundational program that transforms the delivery of AKI care, reduces morbidity and mortality and improves long-term outcomes.
AKINow’s Focus Areas
AKINow Spotlight
AKINow Journal Club Presentation: Roadmap for AKI-D Outpatient Care Recorded May 28, 2025
This guidance provides evidence-based strategies to identify improvements in kidney function early to optimize recovery and potential dialysis liberation, implement individualized care plans distinct from long-term dialysis protocols, and coordinate efforts between various health care personnel for best practices in AKI-D management.
Featured article: ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury
Roadmap for AKI-D Outpatient Care ASN Kidney Health Guidance in JASN
Now available in JASN, the ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury provides nephrologists and kidney health professionals with evidence-based strategies to:
- Identify improvements in kidney function early to optimize recovery and potential dialysis liberation.
- Implement individualized care plans distinct from long-term dialysis protocols.
- Coordinate efforts between patients, caregivers, and various health care personnel for best practices in AKI-D management.Empower your practice with expert insights to enhance improvement in kidney function and to deliver care that optimizes chances of recovery.
Empower your practice with expert insights to enhance improvement in kidney function and to deliver care that optimizes chances of recovery.
AKINow Resource Library
AKINow Journal Club: Intravenous Amino Acids for Kidney Protection Recorded on Dec. 5, 2024
Acute kidney injury (AKI) is a serious and common complication of cardiac surgery. Intravenous amino acids increase kidney perfusion and recruit renal functional reserve. However, the efficacy of amino acids in reducing the occurrence of AKI after cardiac surgery is uncertain. In a multinational, double-blind trial, the authors randomly assigned adult patients who were scheduled to undergo cardiac surgery with cardiopulmonary bypass to receive an intravenous infusion of either a balanced mixture of amino acids or placebo for up to 3 days.
View this Journal Club Presentation to learn the outcome of this research.
AKINow Journal Club: SOX9 Switch Activity Recorded June 20, 2024
Dr. Sanjeev Kumar presents his recent article from Science, on how SOX9 switch activity determines healing with or without fibrosis after AKI.
